IMA Group acquired a majority stake in ProSys Sampling Systems Limited from its co-founder and Treysa Limited. The transaction is a core component of IMA's international growth strategy, aiming to strengthen its "IMA Life" division by integrating specialized containment and sampling expertise. ProSys will continue to operate as an independent business from its headquarters in Ireland, with Michael McLoughlin remaining as Managing Director. This acquisition follows IMA's August 2024 purchase of Sarong's packaging divisions, further consolidating IMA's leadership in the advanced biopharmaceutical technology segment.

This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 12.8x since the beginning of 2026, 1.8% increase compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.